FreeStyle Libre 2
Device
Abbott Laboratories
Total Payments
$3.9M
Transactions
29,118
Doctors
16,519
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $818,412 | 213 | 0 |
| 2023 | $2.2M | 567 | 0 |
| 2021 | $827,510 | 28,338 | 16,519 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.3M | 895 | 85.5% |
| Food and Beverage | $562,042 | 28,198 | 14.5% |
| Education | $1,218 | 23 | 0.0% |
| Long term medical supply or device loan | $123.41 | 2 | 0.0% |
Payments by Type
Research
$3.3M
895 transactions
General
$563,383
28,223 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| HbA1c Variation Study | Abbott Laboratories | $870,262 | 0 |
| Multi-Analyte Studies | Abbott Laboratories | $401,055 | 0 |
| Continuous Glucose Monitoring System Comparison Study | Abbott Laboratories | $363,955 | 0 |
| Exogenous Ketone Drink Study - Pediatric | Abbott Laboratories | $323,839 | 0 |
| Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | Abbott Laboratories | $272,153 | 0 |
| Abbott Sensor Based Monitoring System Multiple Analyte Characterization Study Using Venous and/or Capillary Reference | Abbott Laboratories | $199,099 | 0 |
| FreeStyle Libre 2 Flash Glucose Monitoring System Intervention Phase Study | Abbott Laboratories | $141,436 | 0 |
| A Randomized Controlled Trial Comparing the FreeStyle Libre 2 Continuous Glucose Monitoring vs Point | Abbott Laboratories | $112,500 | 0 |
| Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes: Intervention Arm Extension Study | Abbott Laboratories | $90,077 | 0 |
| FreeStyle Libre 2 Flash Glucose Monitoring System Intervention Phase Study for Pediatric Patients | Abbott Laboratories | $71,062 | 0 |
| Franklin Pilot Study | Abbott Laboratories | $56,514 | 0 |
| A Prospective, Obervational Study of Effectiveness of FreeStyle/FreeStyle Libre 2 in People with Type 2 Diabetes Using Basal Insulin | Abbott Laboratories | $53,630 | 0 |
| Insulin Pump Suspension Study | Abbott Laboratories | $49,333 | 0 |
| JANUS 1 | Abbott Laboratories | $42,336 | 0 |
| T2 FSL2 Weight Loss | Abbott Laboratories | $37,092 | 0 |
| CGM Comparison Study | Abbott Laboratories | $36,966 | 0 |
| A PILOT STUDY COMPARING LIFESTYLE INTERVENTIONS AND INTERMITTENT CONTINUOUS GLUCOSE MONITORING IN PR | Abbott Laboratories | $30,250 | 0 |
| FreeStyle Libre 2 Flash Glucose Monitoring System Control Phase Study for Pediatric Patients - BG | Abbott Laboratories | $26,022 | 0 |
| Ketone Diet Study | Abbott Laboratories | $24,123 | 0 |
| Frequency of Ketosis in People Living with Diabetes or Other Medical Conditions when using Continuous Glucose Monitoring | Abbott Laboratories | $20,515 | 0 |
Top Doctors Receiving Payments for FreeStyle Libre 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Farmington Hills, MI | $3.3M | 895 |
| , FNP-BC | Family | Orchard Park, NY | $753.13 | 8 |
| , M.D | Endocrinology, Diabetes & Metabolism | Jacksonville, FL | $565.85 | 16 |
| , M.D.,F.A.C.E | Endocrinology, Diabetes & Metabolism | Saint Louis, MO | $508.22 | 13 |
| , APRN | Acute Care | Jacksonville, FL | $505.73 | 13 |
| , M.D | Endocrinology, Diabetes & Metabolism | Rockledge, FL | $465.12 | 5 |
| , M.D | Internal Medicine | Mcallen, TX | $456.09 | 9 |
| , M.D | Internal Medicine | Detroit, MI | $456.02 | 18 |
| , MD, FACE | Endocrinology, Diabetes & Metabolism | Granite Bay, CA | $435.65 | 8 |
| , M.D | Family Medicine | Fort Myers, FL | $424.77 | 11 |
| , M.D | Endocrinology, Diabetes & Metabolism | Tulsa, OK | $421.32 | 6 |
| , ANP/GNP | Adult Health | Queens, NY | $416.08 | 8 |
| , M.D | Family Medicine | Morgantown, WV | $412.99 | 6 |
| , M.D | Endocrinology, Diabetes & Metabolism | Smithtown, NY | $378.45 | 7 |
| , NP-C | Family | Saint Louis, MO | $376.63 | 11 |
| , RN, MSN, FNP-C | Family | Upland, CA | $368.55 | 11 |
| , MD, FACE | Endocrinology, Diabetes & Metabolism | Hartford, CT | $367.70 | 12 |
| , M.D | Family Medicine | San Antonio, TX | $365.04 | 3 |
| , CRNP | Family | Berlin, MD | $362.07 | 3 |
| , DO | Family Medicine | Pittsburg, KS | $361.90 | 1 |
| , APRN RD | Nurse Practitioner | Nashville, TN | $361.06 | 19 |
| , APRN-BC, CNS | Adult Health | Beavercreek, OH | $359.43 | 5 |
| , M.D | Endocrinology, Diabetes & Metabolism | Saint Louis, MO | $352.34 | 21 |
| Vikram Dayal | — | Winchester, VA | $344.77 | 3 |
| , M.D | Endocrinology, Diabetes & Metabolism | Cincinnati, OH | $340.91 | 5 |
Ad
Manufacturing Companies
- Abbott Laboratories $3.9M
Product Information
- Type Device
- Total Payments $3.9M
- Total Doctors 16,519
- Transactions 29,118
About FreeStyle Libre 2
FreeStyle Libre 2 is a device associated with $3.9M in payments to 16,519 healthcare providers, recorded across 29,118 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2021 to 2024. In 2024, $818,412 was paid across 213 transactions to 0 doctors.
The most common payment nature for FreeStyle Libre 2 is "Unspecified" ($3.3M, 85.5% of total).
FreeStyle Libre 2 is associated with 20 research studies, including "HbA1c Variation Study" ($870,262).